Vericel Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$45.09

+0.34 (+0.76%)

As of Aug 8, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target -3.3% upside

Low Target $27.22

Average Target $43.60

High Target $49.94

Current Price $45.09

Current
$45.09

Target
$43.60

$27.22 $43.60 avg $49.94

Scenario Analysis

Bear Case

$27.22

-39.6%

Low target

Base Case

$43.60

-3.3%

Avg target

Bull Case

$49.94

+10.8%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$49.32

-8.6% from high

52-Week Low

$28.95

+55.8% from low

Target vs 52W High

$43.60

-11.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%